Changing experience of adverse medical events in the National Health Service: Comparison of two population surveys in 2001 and 2013 by Gray, A, Fenn, P, Rickman, N, Vencappa, D

Donor investment choices in developing countries: a methodology and some illustrative results based on Public-Private partnerships for product development (PD PPPs) by Gray, A, Fenn, P, Garau, M, Godber, E, Towse, A

The Impact of Risk Management Standards on Patient Safety: The Determinants of MRSA Infections in Acute NHS Hospitals, 2001-08 by Fenn, P, Gray, A, Rickman, N, Rivero-Arias, O, Vencappa, D

The Impact of Risk Management Standards on Patient Safety: The Determinants of MRSA Infections in Acute NHS Hospitals, 2001-08 by Fenn, P, Gray, A, Rickman, N, Rivero-Arias, O, Vencappa, D

Donor investment choices in developing countries: a methodology and some illustrative results based on Public-Private partnerships for product development (PD PPPs) by Gray, A, Fenn, P, Garau, M, Godber, E, Pritchard, C, Towse, A

Enterprise Liability, Risk Pooling, and Diagnostic Care by Fenn, P, Gray, A, Rickman, N, Vencappa, D, Rivero, O, Lotti, E

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). by Clarke, P, Gray, A, Briggs, A, Farmer, A, Fenn, P, Stevens, R, Matthews, DR, Stratton, I, Holman, R

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom... by Gray, A, Raikou, M, McGuire, A, Fenn, P, Stevens, R, Cull, C, Stratton, I, Adler, A, Holman, R, Turner, R

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom... by Gray, A, Raikou, M, McGuire, A, Fenn, P, Stevens, R, Cull, C, Stratton, I, Adler, A, Holman, R, Turner, R